EUVIMEDEUVIMED entdecken
Metaanalyse

Outcomes of cardiac myosin inhibitors in hypertrophic cardiomyopathy: an updated brief meta-analysis

Joud Fahed, Asad Ur Rab, Mohammad Hamza, Rehman Afraz, Ali Awad, Abdul Monem Al Riahi, Prakash Upreti

International Journal of Cardiology and Cardiovascular Diseases · 25.05.2026 · 6 (1) · 41

DOI: 10.46439/cardiology.6.039 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Cardiology and Cardiovascular Diseases, online erschienen am 25.05.2026. Verfasst von Joud Fahed und 6 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Fahed, J., Rab, A. U., Hamza, M., Afraz, R., Awad, A., Riahi, A. M. A., & Upreti, P. (2026). Outcomes of cardiac myosin inhibitors in hypertrophic cardiomyopathy: an updated brief meta-analysis. International Journal of Cardiology and Cardiovascular Diseases, 6(1), 41. https://doi.org/10.46439/cardiology.6.039

Vancouver

Fahed J, Rab AU, Hamza M, Afraz R, Awad A, Riahi AMA, et al. Outcomes of cardiac myosin inhibitors in hypertrophic cardiomyopathy: an updated brief meta-analysis. International Journal of Cardiology and Cardiovascular Diseases. 2026;6(1):41. doi:10.46439/cardiology.6.039

BibTeX
@article{Fahed2026,
  author = {Fahed, Joud and Rab, Asad Ur and Hamza, Mohammad and Afraz, Rehman and Awad, Ali and Riahi, Abdul Monem Al and Upreti, Prakash},
  title = {Outcomes of cardiac myosin inhibitors in hypertrophic cardiomyopathy: an updated brief meta-analysis},
  journal = {International Journal of Cardiology and Cardiovascular Diseases},
  year = {2026},
  volume = {6},
  number = {1},
  pages = {41},
  doi = {10.46439/cardiology.6.039}
}
Kostenlos starten →